CompletedNot Applicable

Strengthening of the First Dorsal Interosseous for Thumb Carpometacarpal Osteoarthritis

United States160 participantsStarted 2016-12-29

Plain-language summary

To determine the effect of first dorsal interosseus (FDI) strengthening in patients with thumb carpometacarpal (CMC) osteoarthritis.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * At least 18 years old * English-speaking * Splint treatment for thumb carpometacarpal (CMC) osteoarthritis Exclusion Criteria: * Less than 18 years old * Rheumatoid Arthritis or post-traumatic carpometacarpal (CMC) osteoarthritis * Patients that received a corticosteroid injection during the appointment for treatment of thumb carpometacarpal (CMC) osteoarthritis

What they're measuring

Difference in 3-point chuck strength at 12 weeks

Timeframe: At enrollment and 12 week follow up

Difference in Lateral pinch strength at 12 weeks

Timeframe: At enrollment and 12 week follow up

Visual Analog Scale (VAS) for Pain

Timeframe: At enrollment and 12 week follow up

Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Upper Extremity Computer Adaptive Test (CAT) at 12 weeks

Timeframe: At Enrollment and 12 week follow up

Trial details

NCT IDNCT03177577

SponsorMassachusetts General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-06

View on ClinicalTrials.gov More Thumb Osteoarthritis trials